Ehrnrooth Eva 4
4 · IO Biotech, Inc. · Filed Mar 22, 2023
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Ehrnrooth Eva
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-20+120,000→ 120,000 totalExercise: $1.98Exp: 2033-03-20→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on March 20, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.